Q&A
"1. Question: When was the Middle East Respiratory Syndrome Coronavirus isolated first
    Answer: (MERS-CoV) was first isolated in 2012, in a 60-year-old man who died in Jeddah, KSA due to severe acute pneumonia and multiple organ failure"
"2. Question: Which medical comorbidities most profoundly influenced MERS-CoV outcomes
    Answer: if they were obese, immunocompromised, diabetic or had cardiac disease"
"3. Question: What is the size of bovine coronavirus
    Answer: 31 kb"
"4. Question: What is the estimated R0 of COVID-19
    Answer: 2.2"
"5. Question: What is the relationship between SARS-CoV and acute lung injury (ALI)
    Answer: Many infected patients have acute lung injury (ALI)"
"6. Question: What is the relationship between the presence of virus in anal swabs and disease severity in 2019-nCOV
    Answer: In the anal swab cohort (Figure 1 (B)), 11 of 28 cases were detected to be anal swab positive, 8 of them (72.7%) were with severe symptoms, which was significantly higher than that 4 (23.5%) of the rest 17 cases without detectable virus in anal were severe cases"
"7. Question: What is a key assumption of a semi-mechanistic Bayesian hierarchical model used for coronavirus
    Answer: each intervention has the same effect on the
reproduction number across countries and over time"
"8. Question: What is the genus of the SARS coronavirus
    Answer: Betacoronavirus"
"9. Question: What will be the drug of choice for treating COVID-19 between Chloroquine and Remdesivir
    Answer:  two potential drugs, CQ appears to be the drug of choice for large-scale use due to its availability, proven safety record, and a relatively low cost."
"10. Question: What was the read coverage for the E-30 genome in this study
    Answer: 260-fold"
"11. Question:  What is important for understanding the origin and evolution of this novel lineage B betacoronavirus
    Answer: Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus"
"12. Question: Why might we underestimate the spread of COVID19
    Answer: limited information available regarding incubation time, transmissibility, and virus origin"
"13. Question: What could be the implication of 2019-nCOV virus in anal swabs
    Answer: digestive tract might be one extrapulmonary site for virus replication"
"14. Question: What is the relation between the new2019-nCOV and the conserved orf8
    Answer: the new 2019-nCoV orf8 is distant from the conserved orf8 "
"15. Question: Where does the NLRP3 inflammasome activate after a SARS-CoV infection
    Answer: in lipopolysaccharide-primed macrophages"
"16. Question: What was the fatality rate of the SARS coronavirus outbreak between November 2002 and July 2003
    Answer: 9.60%"
"17. Question: How many nucleotides does bovine coronavirus contain
    Answer: 30,847 nucleotides"
"18. Question: In vitro comparison of antiviral activity of Chloroquine(CQ) and Hydroxychloroquine(HCQ) against COVID-19
    Answer: compare the antiviral activity of CQ versus HCQ, the dose-response curves"
"19. Question: What was a characteristic of SARS-CoV and MERS-CoV specimens collected from the lower respiratory tract such as sputum and tracheal aspirates
    Answer: have higher and more prolonged levels of viral RNA because of the tropism of the virus. "
"20. Question: Why is there no credible evidence to support the claim that the SARS-CoV-2 is derived from the chimeric SL-SHC014-MA15 virus
    Answer: upon careful phylogenetic analyses by multiple international groups [5, 14] , the SARS-CoV-2 is undoubtedly distinct from SL-SHC014-MA15, with >6,000 nucleotide differences across the whole genome."
"21. Question: What animals can carry coronavirus
    Answer: uding birds, farm animals, pets, camels, an"
"22. Question: What COVs were known to infect humans before December 2019
    Answer: 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [ "
"23. Question: What's the recommended method to disinfect floors for COVID-19
    Answer: The ground is wiped with 1000mg/L chlorine-containing
disinfectant, once /4 hours."
"24. Question: How long is the incubation time for COVID19
    Answer: between 2 and 14 days"
"25. Question: What illness is caused by the 2019-nCOV Coronavirus
    Answer: The novel coronavirus (2019-nCoV) infection caused pneumonia. "
"26. Question: What does the orf8 derived from 2019-nCOV belong to
    Answer: the group that includes the closest genome sequences of bat SARS-related-CoV ZXC21 and ZC45. "
"27. Question: What are the steps that a hospital should take after COVID-19 outbreak
    Answer: 2019-nCoV patients should be admitted"
"28. Question: What is the conclusion of the coronavirus long-term surveillance studies
    Answer: Rhinolophus bats seem to harbor a wide diversity of CoVs"
"29. Question: What percentage of people infected with MERS-CoV died
    Answer: 35-50%"
"30. Question: How many COVID deaths occurred in Chinese mainland as of March 11th
    Answer: 3,169"
"31. Question: What other tests should be considered for 2019-nCOV epidemiology
    Answer: serology should be considered for 2019-nCoV epidemiology."
"32. Question: What viruses are similar to the COVID-19 coronavirus
    Answer: MERS-CoV and SARS-CoV."
"33. Question: What tests should be done before a 2019-nCOV infected patient is discharged
    Answer: we cannot discharge a patient purely based on oral swabs negative, who may still shed the virus by oral-fecal route. Above all, we strongly suggest using viral IgM and IgG serological test to confirm an infection, considering the unreliable results from oral swabs detection"
"34. Question: Why early identification of COVID-19 patients can be difficult
    Answer: Early identification of 2019-nCoV infection presents a major challenge"
"35. Question: When did we discover that SARS-CoV-2 was a novel coronavirus
    Answer: 26-Jan-20"
"36. Question: What is the incubation period for MERS-COV
    Answer:  incubation period of 16 days with a mean of 5-6 days ["
"37. Question: When did the United States declare COVID19 a public health emergency
    Answer: January 31, 2020,"
"38. Question: What is the acronym MERS-CoV
    Answer: Middle East respiratory syndrome coronavirus"
"39. Question: How long did it take China to build the temporary hospital in Wuhan for COVID-19 patients
    Answer: 10 days"
"40. Question: Where was hepcidin first discovered
    Answer: human urine"
"41. Question: How many people did SARS-CoV infect
    Answer: 8000"
"42. Question: Which Human Coronavirus showed species specific clinical characteristics of its infection
    Answer: HCoV‐HKU1"
"43. Question: How does gender influence MERS-COV infection
    Answer:  MERS-CoV infects males more than females"
"44. Question: What test could give an indication for special care for 2019-nCOV patients
    Answer: presence of viral RNA outside of the respiratory tract might herald the severity of the disease and alarm the requirement of special care"
"45. Question: When did the Chinese authorities share the sequence of a novel coronavirus 
    Answer: 12-Jan-20"
"46. Question: Is the orf1ab gene at the 3' or 5' end of the bovine coronavirus genome
    Answer: 5= side"
"47. Question: What are the descriptive statistics for the onset-to-death for coronavirus
    Answer: Gamma distributed with a mean of 18.8 days and a
coefficient of va riation 0.45"
"48. Question: What is the molecular structure of bovine coronavirus
    Answer: single-stranded, linear, and nonsegmented RNA"
"49. Question: What is the effect of Chloroquine(CQ) and Hydroxychloroquine(HCQ) on endosomal maturation and endocytosis in COVID-19 treatment
    Answer: Since acidification is crucial for endosome maturation and function, we surmise that endosome maturation might be blocked at intermediate stages of endocytosis,"
"50. Question: What could account for the high transmission rate of the 2019-nCOV virus
    Answer: Intensive structural analysis of the S protein of 2019-nCoV with the SARS-Coronavirus suggested that several critical residues in the viral spike protein might confer favourable interaction with human ACE2 [7] . Of note, ACE2 is also abundantly present in humans in the epithelia of the small intestine besides the respiratory tract and is ubiquitously present in endothelial cells [8] , which might provide possible routes of transmission, and might account for the high transmission capacity of the new virus. "
"51. Question: What was the fatality rate for SARS-CoV
    Answer: 10%"
"52. Question: How do SARS-CoV viral proteins interact with the immune response
    Answer: several viral proteins suppress the type I IFN response, and other aspects of innate antiviral immunity"
"53. Question: What is the contrast with SARS-COV and MERS=COV
    Answer:  SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively "
"54. Question: When did the World Health Organization (WHO) officially declare the 2019-nCoV epidemic as a Public Health Emergency of International Concern
    Answer: 30-Jan-20"
"55. Question: How many COVID-19 cases were confirmed on the Diamond Princess cruise ship
    Answer: Out of a total of 3711 persons (consisting of 2666 passengers and 1045 crew members), 199 symptomatic cases have been diagnosed on board as of 24 February, and additional asymptomatic infections and symptomatic cases after disembarkation have also been reported"
"56. Question: What was the reservoir for SARS-CoV and MERS-CoV
    Answer: animal reservoirs"
"57. Question: How does cell-entry differ between SARS-CoV and MERS-CoV
    Answer: SARS-CoV uses the ACE2 receptor to gain entry to cells, while MERS-CoV uses the ectopeptidase DPP4"
"58. Question: What is the relationship between SARS-CoV and acute respiratory distress syndrome (ARDS)
    Answer:  In some patients there is a progression to the more severe form of ALI, acute respiratory distress syndrome (ARDS)"
"59. Question: How does the transmissibility of 2019-nCOV compare with other viruses
    Answer: 2019-nCoV has potentially higher transmissibility (R0: 1.4-5.5) than both SARS-CoV (R0: [2] [3] [4] [5] and MERS-CoV (R0: 1)"
"60. Question: Why is it proposed that some bat SL-CoVs may be able to directly infect human hosts
    Answer: Combined with evolutionary evidence that the bat ACE2 gene has been positively selected at the same contact sites as the human ACE2 gene for interacting with SARS CoV ["
"61. Question: What was the role of corticosteroid use in hospitalized patients with SARS-CoV
    Answer: Retrospective analysis revealed that, when given at the correct time and to the appropriate patients, corticosteroid use could decrease mortality and also length of hospital stays"
"62. Question: What does the SARS-CoV protein activate
    Answer: NLRP3 inflammasome"
"63. Question: What platform was instrumental in rapid sharing of COVID-19 information
    Answer: Global Initiative on Sharing All Influenza Data (GISAID)"
"64. Question: How many COVID-19 cases were confirmed on the Diamond Princess cruise ship
    Answer: 199"
"65. Question: Evidence of Hydroxychloroquine(HCQ) being anti inflammatory in SARS-CoV-2 critically ill patients with elevated plasma cytokines
    Answer:  HCQ is a safe and successful anti-inflammatory agent"
"66. Question: Where can published genomic sequences be found for the 2019-nCoV virus
    Answer: Global Initiative on Sharing All Influenza Data (GISAID) (https://www.gisaid.org/)"
"67. Question: How do most bat SARSr-COV differ from 2019-nCOV and human SARS-COV
    Answer: bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain (RBD) when compared with that of human SARS-CoV"
"68. Question: When does the infectivity of SARS-COV peak
    Answer: 10 days after illness onset [7] , consistent with the peak in viral load at around that time"
"69. Question: What is a recent discovery
    Answer: Bat is believed to harbor many more viruses than we ever thought as a reservoir host or even a susceptible host "
"70. Question: Which immune factors were associated with increased SARS-CoV morbidity and mortality
    Answer: a higher neutrophil count and low T-cell counts"
"71. Question: What is the RNA of the 2019-nCOV
    Answer: 29891 nucleotides in size, encoding 9860 amino acids"
"72. Question: Why is it statistically impossible to determine which individual intervention had the greatest effect on reducing the coronavirus reproduction number
    Answer: close spacing of interventions in time"
"73. Question: When did the WHO declare COVID to be a Public Health Emergency of International Concern
    Answer: 30-Jan-20"
"74. Question: What type of virus is SARS-CoV-2
    Answer: betacoronavirus"
"75. Question: What were the common HCOV strains in the 5 year USA study
    Answer:  HCoV-OC43 and HCoV-229E"
"76. Question: Why is it highly unlikely that RaTG13 CoV is the immediate source of SARS-CoV-2. 
    Answer: are distributed throughout the genome in a naturally occurring pattern following the evolutionary characteristics typical of CoVs"
"77. Question: What genes have been targeted for the diagnostic RT-PCR tests in 2019-nCoV
    Answer: E and RdRp genes"
"78. Question: What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure
    Answer: The equipment in the contaminated area are wiped with
2000mg/L chlorine-containing disinfectant. The DR and CT gantry in the contaminated
area are wiped with 75% ethanol. The equipment in the buffer area is wiped with
500-1000mg/L chlorine-containing disinfectant or alcohol-containing disposable
disinfectant wipes twice a day."
"79. Question: What is the acronym SARS-CoV-2
    Answer: severe acute respiratory syndrome coronavirus 2 "
"80. Question: What is required for a person to survive a serious SARS-CoV infection
    Answer:  a successful host must not only be able to clear the pathogen, but tolerate damage caused by the pathogen itself and also by the host's immune response"
"81. Question: What factor positively correlates with imported-and-reported cases counts of SARS-CoV-2 infection
    Answer: daily air travel volume"
"82. Question: What are main steps for mitigating the COVID -19 transmission during transport of suspected and confirmed patients
    Answer: firstly, early recognition of the deteriorating patient; secondly, HCW safety; thirdly, bystander safety; fourthly, contingency plans for medical emergencies during transport; fifthly, post-transport decontamination"
"83. Question: What is the recovery benefit of carageenan in patients with any respiratory virus
    Answer: 1.9 day faster recovery from common cold symptoms than placebo treated patients in the intention-to-treat population"
"84. Question: What is the family of the SARS coronavirus
    Answer: Coronaviridae"
"85. Question: For whom does the SARS-COV-2 pose a great threat
    Answer: those in complex humanitarian crises, which lack the infrastructure, support, and health systems to mount a comprehensive response. "
"86. Question: What kind of masks are recommended to protect healthcare workers from COVID-19 exposure
    Answer: N95 mask"
"87. Question: With the intervention of movement restrictions starting on 5th February 2020 what were the confirmed cases for COVID-19, were limited to
    Answer: 102 and 47 cases, respectively."
"88. Question: What age group had the most MERS-COV infections
    Answer: majority of confirmed cases of MERS-CoV were reported among people aged 40 and above"
"89. Question: What is the distance between the p4.7 and p12.7 genes in the Irish versus Japanese equine coronavirus variants
    Answer: 544 base pairs"
"90. Question: What do HCoV-OC43 and HCoV-HKU1 cause
    Answer: self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly "
"91. Question: What thickness of layers is recommended for CT image reconstruction in COVID-19 assessment
    Answer: 1 mm-thick layers"
"92. Question: What animals do gamma and delta coronavirus mainly infect
    Answer: birds"
"93. Question: What is the role of computed tomography (CT) in COVID-19
    Answer: diagnosing and categorizing
COVID-19 on the basis of case definitions issued by the WHO"
"94. Question: What is the estimated infection-to-death distribution's mean for coronavirus
    Answer: 23.9 days"
"95. Question: How does COVID19 get spread
    Answer: close contact with an infected person"
"96. Question: What type of virus is 2019-nCOV
    Answer: betacoronavirus"
"97. Question: Is the SARS coronavirus enveloped
    Answer: enveloped"
"98. Question: How many laboratory-confirmed cases of SARS coronavirus infections were reported between November 2002 and July 2003
    Answer: At least 8,098"
"99. Question: What kind of test can diagnose COVID-19
    Answer: rRT-PCR test"
"100. Question: When was World Health Organization (WHO) first notified about the SARS-CoV-2 epidemic in Wuhan City China
    Answer: 31-Dec"
"101. Question: What are ways in which 2019-nCOV is transmitted
    Answer: We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral–fecal route."
"102. Question: How does transmission differ between SARS-CoV and MERS-CoV
    Answer:  SARS-CoV also spreads more rapidly between hosts, while MERS-CoV has been more easily contained, but it is unclear if this is due to the affected patient populations and regions"
"103. Question: How long did it take to identify the cause of COVID-19
    Answer: 4 weeks"
"104. Question: What is the role of interferon's (IFNs) in the treatment of SARS-CoV
    Answer:  there is some evidence that simultaneous treatment with IFNs could increase the potential benefits"
"105. Question: When was the first local transmission of COVID reported in the United States
    Answer: 30-Jan-20"
"106. Question: Why exposure risk of COVID-19 is very high for ICU staff and what precautions should be taken
    Answer:  substantial exposure risk for ICU staff because of the following reasons"
"107. Question: Where did SARS-CoV-2 originate
    Answer: Wuhan City, China"
"108. Question: When was COVID surveillance implemented in European region
    Answer: 27-Jan-20"
"109. Question: what similarity human SARS-COV and palm civet SARSlike COV share
    Answer:  99.8% homology, with a total of 202 single-nucleotide (nt) variations (SNVs) identified across the genome "
"110. Question: When was SARS-CoV first identified
    Answer: 2003"
"111. Question: What are coronaviruses
    Answer: s are spherical, enveloped, and the largest of positive-strand RNA v"
"112. Question: Where was the second reported case of COVID in the United States
    Answer: Chicago"
"113. Question: How is 2019-nCOV transmitted
    Answer: 2019-nCoV was transmitted through respiratory tract and then induced pneumonia,"
"114. Question: How many amino acids are in the SARS-CoV E protein
    Answer: 76 amino acids"
"115. Question: Is oral swab for detecting 2019-nCOV infection sufficient
    Answer:  patients infected with 2019-nCoV may harbour the virus in the intestine at the early or late stage of disease. It is also worth to note none of the patients with viremia blood had positive swabs. These patients would likely be considered as 2019-nCoV negative through routine surveillance, and thus pose a threat to other people."
"116. Question: Which is the source animal for the MERS-COV
    Answer: Dromedary camels are the major animal source of MERS-CoV transmission to humans."
"117. Question: Why is important to determine the spectrum of clinical manifestations of 2019-nCoV infections
    Answer: because it determines the strength of public health response required."
"118. Question: Who is at greater risk of dying from COVID19
    Answer: patients with underlying medical conditions and the elderly"
"119. Question: When was the first case of COVID19 confirmed in the USA
    Answer: 15-Jan-20"
"120. Question: How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV
    Answer: Though the S1 subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV (Figure 3(A) ), the core domain of RBD (excluding the external subdomain) are highly conserved ("
"121. Question: What was done to test if an intermediate host may not be necessary and that some bat SL-CoVs may be able to directly infect human hosts. T
    Answer:  the exact S gene from bat coronavirus SL-SHC014 was synthesized and used to generate a chimeric virus in the mouse adapted MA15 SARS-CoV backbone. "
"122. Question: What was the SARS-COV-2 reservoir
    Answer: the seafood market"
"123. Question: How can the 2019-nCov spread
    Answer:  from person to person,"
"124. Question: What is an example of a case-based measure against coronavirus
    Answer: strong recommendations or laws to the general
public and primary care about self—isolation when showing COVID-19-like symptoms"
"125. Question: In what species did the COVID-19 virus likely originate
    Answer: bats"
"126. Question: What was the primary threatening clinical finding in patients infected with SARS-CoV and MERS-CoV
    Answer: severe lung pathology"
"127. Question: When was the second COVID19 case reported in the US
    Answer: 24-Jan-20"
"128. Question: How do SARS-CoV and MERS-CoV evade the immune system sensing it's genome
    Answer: SARS-CoV and MERS-CoV are contained in double membrane vesicles"
"129. Question: What is the prognostic role of coinfection in SARS-CoV and MERS-CoV infections
    Answer: One factor that increased disease for patients infected with SARS-CoV and MERS-CoV was infection with other viruses or bacteria"
"130. Question: What is the global coverage of influenza and pneumonia vaccines
    Answer:  By the end of 2015, Haemophilus influenzae type B conjugate vaccination had been introduced in 73 countries, with global coverage estimated at 68%. However, inequities are still apparent among regions: in the Americas coverage is estimated at 90%, while in the Western Pacific it is only 25%. By 2015, pneumococcal conjugate vaccination had been introduced into 54 countries, with global coverage of 35% for three doses of pneumococcal conjugate vaccination for infant populations"
"131. Question: What type of coronavirus was detected in R. affinis and R. sinicus species
    Answer: BtCoV/Rh/YN2012"
"132. Question: What role does initial viral titer play in the prognosis of SARS-CoV and MERS-CoV
    Answer: In patients with high initial viral titers there is a poor prognosis"
"133. Question: How does the pathogenicity of 2019-nCOV compare with other viruses
    Answer: Based on current evidence, pathogenicity for 2019-nCoV is about 3%, which is significantly lower than SARS-CoV (10%) and MERS-CoV (40%)"
"134. Question: In addition to oral swabs, which tests detected the presence of 2019-nCOV virus
    Answer: the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). "
"135. Question: Why were civets proposed to be an intermediate host of the bat-CoVs capable of spreading SARS CoV to humans
    Answer: t was proposed that the S gene from bat-derived CoV, unlike that from human patients-or civetsderived viruses, was unable to use human ACE2 as a receptor for entry into human cells "
"136. Question: Why is there high uncertainty in estimating the impact of interventions against the coronavirus
    Answer: too early to detect substantial
intervention impact in many countries at earlier stages of their epidemic"
"137. Question: What is the estimated mean incubation period for COVID-19 infection on the Diamond Princess cruise ship
    Answer: about 5.0 days"
"138. Question: What is the size of the orf1ab gene in bovine coronavirus
    Answer: 20kb"
"139. Question: Estimated number of people in Italy infected with coronavirus by March 28th
    Answer: cumulatively, 5.9 [1.9-15.2] million people have been
infected as of March 28th"
"140. Question: What type of ion channels are formed by the SARS-CoV E protein
    Answer: Ca 2+ -permeable"
"141. Question: What was the time period of peak infection of COVID-19 on the Diamond Princess cruise ship
    Answer: 2 to 4 February 2020,"
"142. Question: What is the timeline of the type I interferon (IFN) response in SARS-CoV infection
    Answer: In a mouse model of SARS-CoV infection, the type I IFN response is delayed"
"143. Question: What percentage of people infected with SARS-CoV died
    Answer: 10%"
"144. Question: What are the most revealing signs that SARS-CoV-2 evolved by natural evolution. 
    Answer: The absence of a logical targeted pattern in the new viral sequences and a close relative in a wildlife species (bat"
"145. Question: How is COVID-19 spread
    Answer: person-to-person"
"146. Question: What can be the main challenges in managing a hospital outbreak of COVID-19
    Answer:  (1) early identification of outbreak, (2) rapid expansion of patients, (3) high risk of nosocomial transmission, (4) unpredictability of size impacted, and (5) lack of backup resource."
"147. Question: When was SARS-CoV-2 first identified
    Answer: 19-Dec"
"148. Question: What is a natural reservoir of coronavirus
    Answer: Bats"
"149. Question: How many types of coronaviruses are known to cause human disease
    Answer: Six"
"150. Question: What is the structure of the coronavirus
    Answer: enveloped, non-segmented, positive-strand RNA viruses"
"151. Question: When was the first passenger patient on the Diamond Princess cruise ship diagnosed with COVID-19
    Answer: he case was diagnosed on 1 February"
"152. Question: What spurred the discovery of the new vector Ae. albopictus
    Answer: The 2005-2006 epidemic of CHIKV in La Reunion islands in the Indian Ocean,"
"153. Question: What was the prevalence of Coronavirus OC43 in community samples in Ilorin Nigeria
    Answer: 13.3% (95% CI 6.9-23.6%)"
"154. Question: What was the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria
    Answer: 12.50%"
"155. Question: How are 2019-nCOV and SARS-COV similar
    Answer: There are no remarkable differences between the orfs and nsps"
"156. Question: What symptoms might people experience with COVID19
    Answer: patients with underlying medical conditions and the elderly"
"157. Question: What is the doubling time of the COVID-19 pandemic
    Answer: ≈6 days"
"158. Question: Is the SARS coronavirus single-stranded or double-stranded
    Answer: single-stranded"
"159. Question: What is the genome size of the coronavirus
    Answer: 26-32 kb"
"160. Question: What are the descriptive statistics for the incubation period for coronavirus
    Answer: distribution is Gamma distributed with mean 5.1 days and coefficient of variation
0.86"
"161. Question: When was the novel Coronavirus first reported
    Answer: 19-Dec"
"162. Question: Use of SIR/SEIR model in Statistics-Based Predictions of Coronavirus Epidemic Spreading
    Answer: susceptible persons is S, infected (persons who are sick and spread the infection) -I, removed (persons who do not spread the infection anymore, this number is the sum of isolated, recovered and dead people) -R; the infection and immunization rates "
"163. Question: What are the most common symptoms of COVID19
    Answer: Fever and cough "
"164. Question: How much similarity the SARS-COV-2 genome sequence has with SARS-COV
    Answer: ∼80% identity with SARS-CoV"
"165. Question: How does being a smoker impact COVID-19 patient outcomes
    Answer: smokers were 1.4 times more likely (RR=1.4, 95% CI: 0.98–2.00) to have severe symptoms of COVID-19 and approximately 2.4 times more likely to be admitted to an ICU, need mechanical ventilation or die compared to non-smokers (RR=2.4, 95% CI: 1.43–4.04)"
"166. Question: How long did it take to publish the full genomic sequence of SARS-CoV-2 after it was identified
    Answer: 2 weeks"
"167. Question: What type of test was initially developed to screen for SARS-CoV-2
    Answer:  reverse transcription polymerase chain reaction"
"168. Question: What could account for the dissemination of the 2019-nCOV virus across the whole body
    Answer: We propose that rampant coronavirus replication in pulmonary alveolus results in the breakdown of the alveolar vessel and the subsequent virus leakage into the blood flow, through which the virus is disseminated across the whole body. Then the virus succeeds in establishing reinfection in the digestive tract by using the highly expressed ACE2 receptor, which exacerbated the disease vice versa"
"169. Question: Is it possible to get infected with COVID and another virus
    Answer: Although the likelihood of coinfection of 2019-nCoV and another respiratory virus is thought to be low, a positive finding of another respiratory pathogen does not exclude the diagnosis of 2019-nCoV"
"170. Question: What is the Case fatality rate for MERS Coronavirus
    Answer: Recent fatality rate (CFR) of 21%"
"171. Question: What other betacoronaviruses are zoonotic in origin
    Answer: The severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)"
"172. Question: How much is the difference between the human SARS-CoV-2 and the bat RaTG13-CoV
    Answer: greater than 1,100 nt "
"173. Question: How is the SARS-CoV-2 referred to
    Answer:  as coronavirus disease discovered in 2019 (COVID-19)"
"174. Question: What was attributed to the spread of SARS-COV at Amoy Gardens
    Answer: through pressure differentials between contaminated effluent pipes, bathroom floor drains and flushing toilets "
"175. Question: What orf8 length do Human SARS-CoVs isolated from early-phase patients all civet SARS-CoVs and other bat SARS-related CoVs contain
    Answer: fulllength orf8"
"176. Question: Who was the first COVID-19 identified case patient on the Diamond Princess cruise ship
    Answer: case was diagnosed on 1 February, the ship was requested to remain in the ocean near Yokohama from 3 February onwards."
"177. Question: When was the first case of COVID-19 identified
    Answer: Wuhan City, China"
"178. Question: What is the median time until death in MERS-COV
    Answer: median time until death is 11-13 days (range 5-27 days) among severely ill patients"
"179. Question: What is the treatment for MERS-COV
    Answer: ere is no specific treatment for MERS-CoV. Like most viral infections, the treatment options are supportive and symptomatic"
"180. Question: How many states in the U.S. have reported cases of COVID-19
    Answer: 50"
"181. Question: Where and when was 2019-nCOV first identified
    Answer: s first identified in Wuhan, China"
"182. Question: What are Coronaviruses
    Answer: Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA viruses that belong to the subfamily Coronavirinae, family Coronavirdiae, order Nidovirales."
"183. Question: How did the SARS-CoV gain elevated replication and lung pathogenesis in aged mice 
    Answer: due to six coding genetic mutations associated with mouse adaptation. "
"184. Question: Why are Nucleic amplification tests (NAAT) usually preferred as in the case of MERS-CoV diagnosis
    Answer: it has the highest sensitivity at the earliest time point in the acute phase of infection "
"185. Question: What do mild clinical presentations of 2019-nCOV indicate
    Answer: that there could be many more mild infections than severe infections"
"186. Question: What is the difference between the Tokachi09 and Irish coronavirus genomic sequences
    Answer: 148-nucleotide insertion"
"187. Question: Mechanism of action of Chloroquine(CQ) and Hydroxychloroquine(HCQ) against COVID-19
    Answer: CQ and HCQ are weak bases that are known to elevate the pH of acidic intracellular organelles"
"188. Question: Where have most outbreaks of equine coronavirus occurred in the United States
    Answer: adult riding, racing and show horses"
"189. Question: What is the name of the disease caused buy SARS-COV-2
    Answer: coronavirus disease 2019 (COVID -19)"
"190. Question: How does the genome of 2019-vCOV compare with  SARS like viruses and SARS-COV
    Answer: Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses."
"191. Question: What suggests that Irish equine coronaviruses may have a low genetic diversity
    Answer: high level of homology between viruses"
"192. Question: Where was SARS-CoV-2 first identified
    Answer: Wuhan, capital of Hubei Province, China"
"193. Question: What is a major difference in clinical progression between SARS-CoV and MERS-CoV
    Answer: Unlike SARS-CoV infection, which causes primarily a severe respiratory syndrome, MERS-CoV infection can also lead to kidney failure"
"194. Question: How big was the temporary hospital built in Wuhan City for treatment of COVID-19 patients
    Answer: 1000 bed hospital"
"195. Question: Being closest to 2019-nCoV which species do the two bat SARS-related coronavirus ZXC21 and ZC45 infect
    Answer: can infect suckling rats and cause inflammation in the brain tissue, and pathological changes in lung & intestine. "
